➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Johnson and Johnson
Merck
AstraZeneca
McKinsey

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SELUMETINIB SULFATE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Selumetinib Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01085214 AZD6244 (Selumetinib) in Treating Patients With Multiple Myeloma Completed National Cancer Institute (NCI) Phase 2 2010-03-01 This phase II trial studies how well selumetinib works in treating patients with multiple myeloma, a type of cancer in which a specific protein is over active. Selumetinib may stop the growth of cancer cells by blocking this protein.
NCT01116271 Study of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With Colorec Completed AstraZeneca Phase 2 2010-04-01 The purpose of this study is to determine whether treatment with Selumetinib (AZD6244) (Hyd-Sulfate) in combination with Irinotecan as a second treatment in patients with K-ras or B-raf mutation will prevent tumor progression and prolong progression free survival.
NCT01166126 Temsirolimus/AZD 6244 for Treatment-naive With BRAF Mutant Unresectable Stage IV Terminated National Cancer Institute (NCI) Phase 2 2010-10-01 The purpose of this study is to find out how often two investigational drugs that are given together will shrink the patient's tumor and how well they will prolong the time it takes their tumor to grow. The investigators also wish to find out how they affect certain substances in the patient's tumor and in their blood important for tumor growth. The combination of these drugs is experimental, and has not been proven to help treat melanoma
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Selumetinib Sulfate

Condition Name

Condition Name for Selumetinib Sulfate
Intervention Trials
Solid Tumours 5
Neurofibromatosis Type 1 4
Neurofibromatosis 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Selumetinib Sulfate
Intervention Trials
Neurofibromatosis 1 6
Neurofibromatoses 6
Neurofibroma 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Selumetinib Sulfate

Trials by Country

Trials by Country for Selumetinib Sulfate
Location Trials
United States 134
Canada 10
United Kingdom 4
Germany 3
France 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Selumetinib Sulfate
Location Trials
Pennsylvania 9
Florida 9
Maryland 9
New York 7
California 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Selumetinib Sulfate

Clinical Trial Phase

Clinical Trial Phase for Selumetinib Sulfate
Clinical Trial Phase Trials
Phase 3 4
Phase 2 14
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Selumetinib Sulfate
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 7
Recruiting 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Selumetinib Sulfate

Sponsor Name

Sponsor Name for Selumetinib Sulfate
Sponsor Trials
National Cancer Institute (NCI) 17
AstraZeneca 15
Sarcoma Alliance for Research through Collaboration 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Selumetinib Sulfate
Sponsor Trials
NIH 17
Industry 15
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Medtronic
Johnson and Johnson
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.